In: Journal of Neurology, 2021, no. 268, p. 817–824
Background: Data on cancer prevalence and incidence in multiple sclerosis (MS) patients are controversial. This study is aimed at estimating cancer risk in MS patients. Methods: Nested case–control study using data collected between 01/01/1987 and 28/02/2016 from the United Kingdom Clinical Practice Research Datalink. Cancer diagnoses after first MS code (index date) was counted in 10,204 MS...
|
In: Brain, 2016, vol. 139, no. 1, p. 39-46
|
In: The Cerebellum, 2015, vol. 14, no. 3, p. 364-374
|
In: Journal of Neurology, 2015, vol. 262, no. 4, p. 870-880
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2015, vol. 34, no. 10, p. 2049-2055
|
In: Journal of Neurology, 2015, vol. 262, no. 8, p. 1909-1917
|
In: Journal of NeuroVirology, 2015, vol. 21, no. 6, p. 694-701
|
In: SLEEP, 2016, vol. 40, no. 3, p. -
|
In: Frontiers in Neurology, 2019, vol. 10, p. -
Objectives: To assess the ability of 3D amide proton transfer weighted (APTw) imaging based on magnetization transfer analysis to discriminate between multiple sclerosis lesions (MSL) and white matter hyperintensities of presumed vascular origin (WMH) and to compare APTw signal intensity of healthy white matter (healthy WM) with APTw signal intensity of MSL and WHM.Materials and Methods: A...
|
In: PLOS genetics, 2019, vol. 15, no. 4, p. e1008069
In the peripheral nervous system (PNS) myelinating Schwann cells synthesize large amounts of myelin protein zero (P0) glycoprotein, an abundant component of peripheral nerve myelin. In humans, mutations in P0 cause the demyelinating Charcot-Marie-Tooth 1B (CMT1B) neuropathy, one of the most diffused genetic disorders of the PNS. We previously showed that several mutations, such as the...
|